Shares Drop 40% as Allergy Therapeutics Announces Failed Phase III Trial
Allergy Therapeutics has revealed that its immunotherapy for birch pollen allergy did not result in…
18/03/2019 - 2 minutes
Allergy Therapeutics
Positive House Dust Mite Immunotherapy Results for UK Biotech
British biotech Allergy Therapeutics reports positive early-stage results for its house dust mite immunotherapy. It’s…
29/05/2018 - 1 minute
Grass Pollen Allergy Vaccine Gets Encouraging Phase II Results
Allergy Therapeutics has obtained positive Phase II results for its grass pollen allergy vaccine and…
23/05/2018 - 2 minutes
British Rapid Action Allergy Vaccine Gets Approval for Phase II Trial
Allergy Therapeutics' vaccine against hayfever has received approval to begin a trial to determine its…
18/09/2017 - 2 minutes
Suffering from House Dust Mite Allergy? A New Therapy is on its Way
Allergy Therapeutics, a UK-based biotech company, just announced the approval of its clinical trial application…
14/02/2017 - 2 minutes
Germany gains Strength in Allergy Immunotherapeutics
Bencard Allergie is developing ultra-short course allergy immunotherapies, backed by a strong growth in its…
10/02/2017 - 2 minutes
UK Biopharma joins Allergy race with good Phase II results for Hayfever
Allergy Therapeutics has gotten positive results for its phase II trial for birch pollen allergy…
09/05/2016 - 2 minutes
